KomFi. Academy

hard · CFA Level I Financial Statement Analysis

Amberfen Pharma acquires a smaller competitor, resulting in the recognition of 200 million in goodwill. Three years later, Amberfen determines that the reporting unit's fair value has fallen below its carrying amount. Under IFRS, an impairment loss of $50 million is recognized. In the following year, the unit's value recovers.

Amberfen should:

  1. Reverse the 50 million impairment through profit and loss
  2. Maintain the carrying value at the impaired level
  3. Reverse the impairment only through Other Comprehensive Income

Sign up free to see the explanation and track your rank →

More CFA Level I Financial Statement Analysis practice

All Financial Statement Analysis questions · CFA Level I study guide · CFA Level I glossary · CFA Level I flashcards